Advertising Disclosure: This website may receive compensation for products and services featured on this site. Our reviews and ratings are based on independent research and editorial opinions. For more details, see our advertising disclosure.

GLP1RatingsUS.com

Trademark Disclaimer

Home Trademark Disclaimer

Ownership of Trademarks and Brand Names

All product names, brand names, trade names, trademarks, registered trademarks, service marks, and logos referenced on GLP1RatingsUS.com are the exclusive property of their respective owners. The use of any trademark, brand name, or product name on this website is strictly for identification, reference, and informational purposes and does not imply any ownership, affiliation, sponsorship, endorsement, or partnership between GLP1RatingsUS.com and the trademark holders.

The following trademarks and brand names are among those referenced on this website, and each is the property of its respective owner:

  • Ozempic® is a registered trademark of Novo Nordisk A/S. Ozempic is an FDA-approved prescription medication containing Semaglutide, originally indicated for type 2 diabetes management and also prescribed off-label for weight loss.
  • Wegovy® is a registered trademark of Novo Nordisk A/S. Wegovy is an FDA-approved prescription medication containing Semaglutide, specifically indicated for chronic weight management in adults with obesity or overweight with weight-related comorbidities.
  • Mounjaro® is a registered trademark of Eli Lilly and Company. Mounjaro is an FDA-approved prescription medication containing Tirzepatide, indicated for the treatment of type 2 diabetes and also used off-label for weight management.
  • Zepbound® is a registered trademark of Eli Lilly and Company. Zepbound is an FDA-approved prescription medication containing Tirzepatide, specifically indicated for chronic weight management in adults with obesity or overweight with weight-related conditions.
  • Semaglutide and Tirzepatide are international nonproprietary names (INNs) for the active pharmaceutical ingredients found in the branded medications listed above. References to these names on our website refer to the drug compounds themselves and do not imply endorsement by or affiliation with any manufacturer.
  • Rybelsus® is a registered trademark of Novo Nordisk A/S. Rybelsus is an oral formulation of Semaglutide approved for the treatment of type 2 diabetes.

Any additional brand names, product names, company names, or trademarks mentioned throughout this website that are not explicitly listed above are similarly the property of their respective owners and are used on this site solely for identification and informational purposes.

No Affiliation or Endorsement

GLP1RatingsUS.com is an independently owned and operated editorial comparison website. We are not affiliated with, endorsed by, sponsored by, or in any way officially connected with Novo Nordisk A/S, Eli Lilly and Company, or any other pharmaceutical manufacturer, healthcare provider, telehealth platform, or pharmacy whose products or services may be mentioned on our site. Any impression of affiliation, endorsement, or sponsorship is unintended and should not be inferred from the presence of any trademark or brand name on our platform.

The appearance of third-party trademarks on GLP1RatingsUS.com does not constitute or imply an endorsement, recommendation, or certification of our website, our content, or our services by the owners of those trademarks. Similarly, our mention of specific branded medications, telehealth providers, or weight loss programs does not indicate that those entities have reviewed, approved, or authorized the content we publish about their products or services.

We operate independently and form our own editorial opinions based on publicly available information, published clinical data, provider-disclosed program details, and our internal research methodology. The trademark holders listed on this page have not participated in the creation, review, or approval of any content on GLP1RatingsUS.com unless explicitly stated otherwise.

Fair Use and Nominative Use of Trademarks

GLP1RatingsUS.com uses the trademarks and brand names listed on this page under the principles of nominative fair use as recognized under United States trademark law. Nominative fair use permits the use of another party's trademark to refer to the trademark owner's own products or services, provided that the use meets certain conditions: the product or service is not readily identifiable without the use of the trademark, only as much of the trademark is used as is reasonably necessary for identification, and the use does not suggest sponsorship or endorsement by the trademark holder.

We reference these trademarks solely because they are necessary to accurately identify and describe the GLP-1 medications and weight loss programs that are the subject of our editorial reviews and comparisons. Without using these brand names, it would not be possible to provide our readers with clear, useful, and accurate information about the products and programs available in the United States GLP-1 weight loss market.

We make every effort to use trademarks in a manner that is accurate, respectful, and consistent with their owners' established branding. Where applicable, we use the ® or ™ symbols to acknowledge the registered or trademarked status of these names. If any trademark owner believes that their mark is being used on our site in a manner that is inaccurate, misleading, or otherwise objectionable, we invite them to contact us through our Contact Us page so that we may promptly address the concern.

Third-Party Content and External References

GLP1RatingsUS.com may contain links to third-party websites, references to external clinical studies, and citations of publicly available information published by pharmaceutical companies, government agencies, medical journals, and other sources. These references are provided for informational purposes only and do not imply any endorsement or affiliation between GLP1RatingsUS.com and the referenced third parties.

The trademarks, logos, and brand names of third-party websites and services that may appear on our site as part of external links or citations are the property of their respective owners. GLP1RatingsUS.com does not claim any rights to those marks, and their inclusion on our platform is solely for the purpose of providing accurate attribution and enabling readers to access additional information from authoritative sources.

We are not responsible for the accuracy, content, or availability of any external websites or resources linked from our platform. Visiting third-party websites is at your own risk and subject to those sites' own terms of service and privacy policies.

Changes to This Disclaimer

GLP1RatingsUS.com reserves the right to update or modify this Trademark Disclaimer at any time without prior notice. As new products enter the market, trademarks are registered or updated, or our content evolves, we may revise this page to reflect those changes. We encourage visitors to review this disclaimer periodically to remain informed about how we reference third-party trademarks and brand names.

If you are a trademark owner and have questions or concerns about how your mark is used on this website, or if you would like to request a correction or update, please reach out to us via our Contact Us page. We are committed to respecting the intellectual property rights of all trademark holders and will respond to legitimate inquiries in a timely manner.

Last Updated: May 2026